FTY720 For Relapsing Multiple Sclerosis - Phase II Data Shows ...
Medical News Today (press release) - UK
... both clinical relapses and inflammatory disease activity are maintained over 18 months," said Dr. Paul O'Connor, MD, St. Michael's Institute, Toronto, Canada. ...

Long-Term Data for Fingolimod Show Significant Efficacy and Safety ...
DG News - USA
... disease activity are maintained over 18 months," said Paul O'Connor, MD, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Dr. O'Connor ...